The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Hemmons, who is a family physician practising in northern British Columbia, wanted to get her a dose of nirsevimab, which can protect babies from respiratory syncytial virus (RSV). But the ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...